These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 61862)

  • 41. Interaction of drugs and Chinese herbs: pharmacokinetic changes of tolbutamide and diazepam caused by extract of Angelica dahurica.
    Ishihara K; Kushida H; Yuzurihara M; Wakui Y; Yanagisawa T; Kamei H; Ohmori S; Kitada M
    J Pharm Pharmacol; 2000 Aug; 52(8):1023-9. PubMed ID: 11007075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between distribution, elimination and anticoagulant action of dicumarol.
    Jähnchen E; Levy G
    J Pharmacol Exp Ther; 1974 Feb; 188(2):293-9. PubMed ID: 4129954
    [No Abstract]   [Full Text] [Related]  

  • 43. Dicoumarol: A Drug which Hits at Least Two Very Different Targets in Vitamin K Metabolism.
    Timson DJ
    Curr Drug Targets; 2017; 18(5):500-510. PubMed ID: 26201483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Specificity of the inhibitory effect of dextropropoxyphene on oxidative drug metabolism in man: effects on theophylline and tolbutamide disposition.
    Robson RA; Miners JO; Whitehead AG; Birkett DJ
    Br J Clin Pharmacol; 1987 Jun; 23(6):772-5. PubMed ID: 3606937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of phenyramidol and bishydroxycoumarin on the metabolism of tolbutamide in human subjects.
    Solomon HM; Schrogie JJ
    Metabolism; 1967 Nov; 16(11):1029-33. PubMed ID: 4168588
    [No Abstract]   [Full Text] [Related]  

  • 46. Evaluation of potential inductive effects of aprepitant on cytochrome P450 3A4 and 2C9 activity.
    Shadle CR; Lee Y; Majumdar AK; Petty KJ; Gargano C; Bradstreet TE; Evans JK; Blum RA
    J Clin Pharmacol; 2004 Mar; 44(3):215-23. PubMed ID: 14973304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dicoumarol relieves serum withdrawal-induced G0/1 blockade in HL-60 cells through a superoxide-dependent mechanism.
    Bello RI; Gómez-Díaz C; López-Lluch G; Forthoffer N; Córdoba-Pedregosa MC; Navas P; Villalba JM
    Biochem Pharmacol; 2005 Jun; 69(11):1613-25. PubMed ID: 15896341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of bilirubin on the distribution, elimination and anticoagulant action of dicumarol in Gunn rats-1-2 (38547).
    Wingard LB; Oie S; Levy G
    Proc Soc Exp Biol Med; 1975 Feb; 148(2):397-401. PubMed ID: 47634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of insulin and glucose in the induction of hypoaminoacidemia in man: studies in normal, juvenile diabetic, and insuloma patients.
    Adibi SA; Morse EL; Amin PM
    J Lab Clin Med; 1975 Sep; 86(3):395-409. PubMed ID: 168278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cotrimoxazole as an inhibitor of oxidative drug metabolism: effects of trimethoprim and sulphamethoxazole separately and combined on tolbutamide disposition.
    Wing LM; Miners JO
    Br J Clin Pharmacol; 1985 Nov; 20(5):482-5. PubMed ID: 3878154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo pharmacokinetic interaction by ethanolic extract of Gymnema sylvestre with CYP2C9 (Tolbutamide), CYP3A4 (Amlodipine) and CYP1A2 (Phenacetin) in rats.
    Vaghela M; Sahu N; Kharkar P; Pandita N
    Chem Biol Interact; 2017 Dec; 278():141-151. PubMed ID: 29042257
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between plasma protein binding, distribution, and anticoagulant action of dicumarol.
    Levy G
    Ann N Y Acad Sci; 1973 Nov; 226():195-9. PubMed ID: 4129138
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacokinetic interaction studies of tanshinones with tolbutamide, a model CYP2C11 probe substrate, using liver microsomes, primary hepatocytes and in vivo in the rat.
    Wang X; Lee WY; Or PM; Yeung JH
    Phytomedicine; 2010 Mar; 17(3-4):203-11. PubMed ID: 19679455
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of magnesium hydroxide on the absorption and efficacy of tolbutamide and chlorpropamide.
    Kivistö KT; Neuvonen PJ
    Eur J Clin Pharmacol; 1992; 42(6):675-9. PubMed ID: 1623912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. On the question of an interaction between sulindac and tolbutamide in the control of diabetes.
    Ryan JR; Jain AK; McMahon FG; Vargas R
    Clin Pharmacol Ther; 1977 Feb; 21(2):231-3. PubMed ID: 837641
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Carbenoxolone interactions in man--preliminary report.
    Thornton PC; Papouchado M; Reed PI
    Scand J Gastroenterol Suppl; 1980; 65():35-9. PubMed ID: 6937939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of total plasma concentration and age on tolbutamide plasma protein binding.
    Adir J; Miller AK; Vestal RE
    Clin Pharmacol Ther; 1982 Apr; 31(4):488-93. PubMed ID: 7060330
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective inhibition of drug oxidation after simultaneous administration of two probe drugs, antipyrine and tolbutamide.
    Back DJ; Tjia J; Mönig H; Ohnhaus EE; Park BK
    Eur J Clin Pharmacol; 1988; 34(2):157-63. PubMed ID: 3383988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
    Johnsson G; Regàrdh CG
    Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
    Walzer M; Bekersky I; Blum RA; Tolbert D
    Pharmacotherapy; 2012 Apr; 32(4):340-53. PubMed ID: 22422635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.